Côte d'Ivoire

in page functions
[French]
Côte d'Ivoire
Total population (2017) 23,815,871
Birth cohort (2017) 867,243
Surviving Infants (surviving to 1 year per year, 2017) 811,894
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 67/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 93/1000
World Bank Index, IDA (2015) 3.28
Gross Nation Income (per capita US$, 2015) 1,420
Co-financing group (2017) Preparatory transition
No. of districts/territories (2015) 82

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Côte d'Ivoire

Type of support

Approvals

2001-2021 (US$)
(23 May 2017)

Commitments

2001-2021 (US$)
(23 May 2017)

Disbursements

2000-2017 (US$)
(23 May 2017)

% Disbursed

(23 May 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $123,172,888 $192,458,888 $119,153,126
Cash Support (CASHSUPP) $182,500 $207,500 $182,500 100%
Health system strengthening (HSS 1) $8,179,615 $8,179,615 $8,179,615 100%
HPV Demo (NVS) $279,774 $279,774 $279,774 100%
Immunisation services support (ISS) $8,925,000 $8,925,000 $8,925,000 100%
Injection Safety Devices (NVS) $250,500 $1,051,500 $306,896 123%
Injection safety support (INS) $1,612,989 $1,612,989 $1,612,989 100%
IPV (NVS) $1,568,822 $1,568,822 $996,622 64%
Meningitis A - campaign (NVS) $3,236,747 $3,236,747 $3,236,747 100%
Meningitis A - operational costs (OPC) $2,804,500 $2,804,500 $2,804,500 100%
Penta (NVS) $38,427,231 $48,006,231 $37,194,342 97%
Pneumo (NVS) $30,163,715 $58,994,715 $34,050,646 113%
Product Switch Grant (PSG) $242,500 $242,500
Rotavirus (NVS) $10,886,875 $40,936,875 $4,971,375 46%
Tetra DTP-HepB (NVS) $11,379,406 $11,379,406 $11,379,406 100%
Vaccine Introduction Grant (VIG) $2,293,000 $2,293,000 $2,293,000 100%
YF - Operational costs (OPC) $2,739,714 $2,739,714 $2,739,714 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Côte d'Ivoire DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 91%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2011) 66.30%
Household survey: DTP3 coverage for female (2011) 61.50%
Household survey: Last DTP3 survey (2011) 64%
% districts achieving > 80% DTP3 coverage (2015) 91%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 72%

Breakdown of support

Non-vaccine support Vaccine support
22% 78%
$26,737,318 $92,415,808

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Côte d'Ivoire

08 December 2016

Immunisation in Côte d’Ivoire on the road to recovery

After five years of devastating conflict, Côte d’Ivoire’s immunisation rates are back to their pre-war levels. In this short film, originally played at the December 2016 Gavi Board meeting in Abidjan, Health Minister Dr Raymonde Goudou Coffie, explains her country’s rapid recovery.

08 December 2016

2016 Cote d'Ivoire

Peace, Progress and Public Health: Côte d'Ivoire on the road to recovery

Five years ago the Côte d’Ivoire was hit by a civil war that claimed thousands of lives and ravaged the nation’s healthcare system. Today, immunisation coverage is almost back up to its pre-war level. How has the country turned round its immunisation rates so quickly?

07 December 2016

CEO Board update December 2016

Dr Seth Berkley presents a general update to the Gavi Board meeting in Côte d’Ivoire, reporting on previous Board decisions, global health threats and how the Alliance is gearing up to deliver on the new strategy.

close icon

modal window here